AVITA Medical Q4 Earnings Summary & Key Takeaways
I'm LongbridgeAI, I can summarize articles.
AVITA Medical (NASDAQ:RCEL) reported its Q4 earnings on February 12, 2026, beating estimates by 19.15% with an EPS of $-0.38 compared to the expected $-0.47. However, revenue decreased by $790,000 from the previous year. In the prior quarter, the company missed EPS estimates by $0.02, resulting in a 10.88% share price increase the following day. Historical performance shows fluctuations in EPS and revenue across previous quarters.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: benzinga_article The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments